Provided by Tiger Trade Technology Pte. Ltd.

Synchrony

71.77
+0.26000.36%
Post-market: 71.770.00000.00%19:30 EDT
Volume:3.12M
Turnover:224.18M
Market Cap:23.35B
PE:7.35
High:72.45
Open:72.03
Low:71.37
Close:71.51
52wk High:88.77
52wk Low:63.08
Shares:325.30M
Float Shares:323.00M
Volume Ratio:1.15
T/O Rate:0.97%
Dividend:1.20
Dividend Rate:1.67%
EPS(TTM):9.77
EPS(LYR):9.28
ROE:20.79%
ROA:2.90%
PB:1.54
PE(LYR):7.73

Loading ...

U.S. Earnings Preview: Before Market Open April 21

Dow Jones
·
Apr 21

Notable companies reporting before tomorrow’s open

TIPRANKS
·
Apr 21

What to Watch in the Day Ahead - Tuesday, April 21

Reuters
·
Apr 21

Is Synchrony (SYF) Quietly Redefining Its Digital Partnership Strategy With RH And Walmart Moves?

Simply Wall St.
·
Apr 19

Synchrony Financial Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Apr 17

Synchrony Financial (SYF) Valuation Check After A Strong 1 Month Share Price Gain

Simply Wall St.
·
Apr 16

Synchrony Financial Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 15

Earning Preview: Synchrony this quarter’s revenue is expected to decrease by 4.80%, and institutional views are bearish

Earnings Agent
·
Apr 15

Synchrony study finds cost deters vision care; 44% willing to switch providers for financing

Reuters
·
Apr 10

Synchrony price target lowered to $95 from $100 at Wells Fargo

TIPRANKS
·
Apr 09

Analysts Offer Insights on Financial Companies: Synchrony Financial (SYF) and Navient (NAVI)

TIPRANKS
·
Apr 09

Synchrony price target lowered to $73 from $84 at JPMorgan

TIPRANKS
·
Apr 09

UBS Adjusts Synchrony Financial Price Target to $77 From $82, Maintains Neutral Rating

MT Newswires Live
·
Apr 07

Synchrony price target lowered to $77 from $82 at UBS

TIPRANKS
·
Apr 07

Synchrony CareCredit expands Walmart partnership with online acceptance on Walmart.com

Reuters
·
Apr 07

Autonomous Research Adjusts PT on Synchrony Financial to $73 From $81, Maintains Neutral Rating

MT Newswires Live
·
Apr 07

Synchrony Financial Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 06

Stereotaxis wins FDA 510(k) clearance for Synchrony cath lab digitization system

Reuters
·
Apr 06

Barclays Adjusts Price Target on Synchrony Financial to $82 From $93, Maintains Overweight Rating

MT Newswires Live
·
Apr 06

Synchrony price target lowered to $82 from $93 at Barclays

TIPRANKS
·
Apr 06